The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
about
Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsInterferons in Sjögren's Syndrome: Genes, Mechanisms, and EffectsClinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis siccaPersistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposureIdentification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cellsClinical Efficacy and Safety of Total Glucosides of Paeony for Primary Sjögren's Syndrome: A Systematic Review.Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic backgroundAltered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.Mouse Models of Primary Sjogren's Syndrome.The lived experience of Sjögren's Syndrome.Activation of HIF-1α (hypoxia inducible factor-1α) prevents dry eye-induced acinar cell death in the lacrimal glandInducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 miceB-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureHeat shock proteins and chronic fatigue in primary Sjögren's syndrome.ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.Single-cell analysis of glandular T cell receptors in Sjögren's syndrome.Epstein-Barr virus in systemic autoimmune diseasesPotential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.Risk of Chronic Obstructive Pulmonary Disease in Female Adults With Primary Sjögren Syndrome: A Nationwide Population-Based Cohort Study.Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndromeIn vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.Hepatitis C virus infection and autoimmune diseases.Th17 cells in autoimmune diseases.Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.Severe dental caries as the first presenting clinical feature in primary Sjögren's syndrome.Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.Bilateral Internuclear Ophthalmoplegia as a Presenting Manifestation of Primary Sjögren's Syndrome.Genetic associations to germinal centre formation in primary Sjogren's syndrome.Low Levels of IgG Recognizing the α-1-Antitrypsin Peptide and Its Association with Taiwanese Women with Primary Sjögren's Syndrome.Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations.Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
P2860
Q26780324-1D552CB7-99D6-4502-ACAA-58BDE316BF5BQ26865427-F690D0E6-05ED-4074-9F1B-226B18C0B658Q28389937-33D58F69-21BF-421D-97D9-CA017A8EDCB1Q28660263-8FC7AF80-112F-492A-949F-098202F2584EQ30836404-D5529A7F-D10A-404C-943B-677E82A50F63Q33659118-508A3157-2DFC-44EC-B75A-E82D4162D497Q33744508-2907FF94-E9EB-40C4-983D-FC58BD66D4DCQ33794924-4E3FA995-E791-4C3D-98CC-CEF82DF5C42CQ34623231-BA479B06-768A-443A-83E8-8C9BE6BE230DQ34669630-7092258F-EC64-4ED6-89D5-38DB2A450495Q35006085-38A5FBE3-B76B-49F2-ADE7-06298C032C1EQ35196207-7F603A76-44CC-4A62-8FB3-9A7FE7D9BE7DQ35587450-018AAACB-5C91-42D7-ABA0-21542FFE55EFQ35910434-48FC86EC-2741-41D7-8646-ECFA7A9CB748Q36179631-4C5B0314-6BF6-45FD-B43B-1CF5C66A573BQ36253046-1AFACD2F-AEFF-44CE-8D56-0D5F9897BD52Q36481706-0326C18B-6350-494A-835F-24C361D89D8AQ36719483-94F1179D-086D-4E32-8BEB-AB5F7C0A0187Q36785406-63098947-5A7C-4F9D-B833-BC6C6104BC29Q37041516-C22C99E2-B3A6-4C89-993E-5E3F2684D592Q37154847-BC73DD08-7A51-4511-B6A2-B7A5EEBA04E1Q37165647-92FE1A72-DDF5-4B2D-B2AA-4BEB302C9CD0Q37207194-3157C7EC-3FD0-439F-9FAA-D88786D5F4ECQ37284248-1461287A-6B10-4BDF-863E-B58B7C202DAAQ37689751-8D21D759-91E3-4843-A245-8D330DA547AFQ38057221-36AE8534-D0B6-4BEE-B95A-BC68F120E9F3Q38344543-29E3BA7F-7745-4814-916D-88B40C2C4A74Q38645543-322CE5EC-2260-4325-86F2-DC50E4415A8FQ39356677-09165354-B182-4FEA-B892-1CD84AEBBA63Q40462144-15CE6890-CD70-4853-8EAB-2EA26C418297Q41040922-89224388-978B-435D-AA66-61636CC4F8B7Q42077832-0DE95037-20F8-4261-BCE8-D32A957FF76FQ42151638-0FA1879C-1D58-4A9A-878E-E23790186730Q42184997-D2E24433-AA3D-42BE-9661-4954847711DEQ42363500-5720B496-00D0-4F40-AED2-4C938E1C7FD3Q43676169-FD832E86-7969-483F-A7CC-DB193E30AC4CQ47274670-DECFE89A-8911-4873-9A6E-9C0719A21015Q47589503-12B095F1-ABC6-4E52-BBC9-FB9AFEF9B69FQ47601511-C2967E08-47C8-4B14-A0D8-6056927DEF5BQ47634458-2C3351C0-EFD3-49CC-B85C-FCFB0DF8A800
P2860
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@ast
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@en
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@nl
type
label
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@ast
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@en
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@nl
prefLabel
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@ast
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@en
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@nl
P2093
P1433
P1476
The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
@en
P2093
Alexander Espinosa
Petra Vogelsang
Roland Jonsson
Roman Volchenkov
P356
10.1016/J.IMLET.2011.06.007
P577
2011-07-12T00:00:00Z